Relative calm enveloped Wall Street, with stocks rising as traders parsed a batch of corporate outlooks. Treasuries bounced from session lows as a $22 billion sale of 30-year bonds showed ...

Trade talks ahead of July 9 cut-off, Netanyahu meets US president and UK Post Office IT scandal inquiry publishes its first ...

How Moderna Went From Pandemic Hero to Vaccine Victim The biotech's mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to vaccine rules.

CAMBRIDGE, MA / ACCESS Newswire / May 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the first quarter of 2025. "In the first quarter, we ...

Moderna Inc. (NASDAQ:MRNA) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ETCompany ParticipantsStéphane Bancel - Chief Executive OfficerStephen ...

Thank you, Kevin. Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's second quarter 2024 financial results and business update. You can access the press ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.28 billion in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based ...

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.28 billion in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based ...

Moderna’s financial results for the second quarter of 2024 reveal a mixed bag of outcomes. The company reported total revenue of $241 million, down from $344 million in the same period last year ...